Stock Signals
A 0 to 100 Signal Score that flags unusual volume, momentum and 52-week activity to surface names worth a closer look. Not advice, not a prediction, and not yet backtested. Always do your own research. How scoring works →
0 high-signal · hourly
⚠️ Read this: a high score means a stock is showing unusual activity right now. It is not a buy recommendation and is not a forecast of future gains. The scoring model has no published track record yet. Treat this as a starting point for research, never a reason to trade.
🚨 Get BUY-signal alerts
Free email the moment a stock crosses a 75+ Signal Score. No spam, unsubscribe anytime.
| # | Stock⇅ | Score▼ | Price⇅ | 1D⇅ | 1W⇅ | 1M⇅ | Mkt cap⇅ |
|---|---|---|---|---|---|---|---|
| 01 | HALO Halozyme Therapeutics Inc | 48 | $108.44 | +2.06% | -1.06% | -0.23% | $12.1B |
| 02 | TGTX TG Therapeutics Inc | 43 | $55.85 | +5.30% | -3.12% | -0.55% | $8.2B |
| 03 | FOLD Amicus Therapeutics Inc | 40 | $14.49 | +0.00% | +0.21% | +0.21% | $4.5B |
| 04 | ABBV AbbVie Inc | 35 | $262.51 | -0.20% | +4.83% | +2.58% | $456.3B |
| 05 | EXEL Exelixis Inc | 28 | $56.78 | -0.21% | -2.45% | +4.14% | $14.1B |
| 06 | LLY Eli Lilly and Co | 25 | $1,137.82 | +0.15% | +1.28% | -1.59% | $1.1T |
| 07 | BIIB Biogen Inc | 24 | $216.01 | -0.07% | +2.58% | -0.22% | $31.9B |
| 08 | MRK Merck & Co Inc | 22 | $144.91 | +0.78% | -2.43% | -1.97% | $354.3B |
| 09 | VRTX Vertex Pharmaceuticals Inc | 22 | $513.26 | -0.27% | -1.78% | -4.59% | $130.6B |
| 10 | REGN Regeneron Pharmaceuticals Inc | 16 | $774.61 | +0.06% | -2.04% | -0.67% | $80.2B |
| 11 | ACAD ACADIA Pharmaceuticals Inc | 15 | $27.54 | +2.91% | -3.32% | -7.44% | $4.7B |
| 12 | GILD Gilead Sciences, Inc | 14 | $147.68 | +0.94% | +0.45% | -0.03% | $181.4B |
| 13 | BMRN BioMarin Pharmaceutical Inc | 10 | $64.73 | +0.43% | +0.06% | -1.20% | $12.5B |
| 14 | ALNY Alnylam Pharmaceuticals Inc | 10 | $239.36 | +0.46% | -7.65% | -1.01% | $32.5B |
| 15 | AMGN Amgen Inc | 10 | $376.35 | +0.19% | -3.99% | -12.62% | $204.3B |
| 16 | MRNA Moderna Inc | 8 | $145.62 | +1.29% | +4.53% | +4.52% | $57.4B |
| 17 | NVO Novo Nordisk A/S | 4 | $41.71 | -1.93% | -3.97% | -4.10% | $1.2T |
| 18 | INSM Insmed Inc | 3 | $122.58 | +2.22% | -6.89% | -1.56% | $26B |
| 19 | SRPT Sarepta Therapeutics Inc | 0 | $19.76 | -4.63% | -0.10% | -0.52% | $2.2B |
| 20 | VKTX Viking Therapeutics Inc | 0 | $29.52 | -1.44% | -6.38% | -3.81% | $3.7B |
| 21 | PFE Pfizer Inc | 0 | $27.46 | -0.33% | -0.25% | -2.60% | $157B |
| 22 | RXRX Recursion Pharmaceuticals Inc | 0 | $3.19 | -1.54% | -0.87% | +0.29% | $1.8B |
| 23 | RARE Ultragenyx Pharmaceutical Inc | 0 | $12.88 | -1.45% | -8.53% | -46.01% | $1.3B |
| 24 | DNA Ginkgo Bioworks Holdings Inc | 0 | $7.06 | +1.00% | +2.95% | +2.64% | $472.1M |
| 25 | IONS Ionis Pharmaceuticals Inc | 0 | $44.84 | -5.10% | -15.66% | -21.72% | $7.9B |
| 26 | ARWR Arrowhead Pharmaceuticals Inc | 0 | $65.79 | -6.91% | -14.47% | -14.22% | $10B |
| 27 | BNTX Biontech SE | 0 | $95.83 | -0.89% | -1.47% | -4.84% | $24.8B |
| 28 | CRSP CRISPR Therapeutics AG | 0 | $52.21 | +0.73% | -3.03% | -9.04% | $5B |
| 29 | NTLA Intellia Therapeutics Inc | 0 | $11.49 | +1.14% | -6.83% | -6.76% | $1.6B |
| 30 | BEAM Beam Therapeutics Inc | 0 | $23.10 | -0.52% | -7.77% | -21.10% | $2.5B |